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Abstract
Ultrasonic vocalizations are widely used to examine affective states in rats, yet relatively few studies explore the acoustic features of vocalizations, especially in relation
to drug exposure, and no studies have explored alterations in acoustic features over
time. The goal of this study was to examine nicotine- and phencyclidine-induced alterations of bandwidth, duration, and frequency of 50 kHz vocalizations. The minimum and maximum frequency, bandwidth, and duration of calls were examined
after 7 days of daily subcutaneous administration of phencyclidine (2.0 mg/kg) and
nicotine (0.2 and 0.4 mg/kg) in male Sprague-Dawley rats. Bandwidth was significantly decreased in rats treated with both nicotine (0.2 and 0.4 mg/kg) and phencyclidine. Maximum frequency was lowest on the first day of exposure compared
with all other days and was not altered by drug exposure. Call duration was not affected by time or drug exposure. These findings suggest the importance of studying
alterations in acoustic features in time, especially those induced by drug exposure.
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Introduction
Ultrasonic vocalizations (USVs) are widely considered a parameter for
emotional states in adult rats (Knutson et al., 2002; Brudzynski, 2005,
2007; Panksepp, 2005; Schwarting et al., 2007) and can be divided into
two main categories based on a general frequency range: 22 and 50
kHz. Although 22-kHz USVs are associated with negative or distressing situations (Litvin et al., 2007), 50-kHz USVs are typically emitted in
response to appetitive contexts and pleasurable stimuli (Knutson et
al., 1999; Burgdorf et al., 2000; Brudzynski, 2005). USVs in the 50 kHz
range have also been utilized as a measure of drug reward (Thompson et al., 2006; Ahrens et al., 2009; Mu et al., 2009; Williams and Undieh, 2010).
Myriad psychoactive drugs with addictive and rewarding properties have acutely produced alterations in total 50-kHz USVs as well as
specific subtypes of vocalizations, including amphetamine, cocaine,
and methylphenidate (Williams and Undieh, 2010; Wright et al., 2010;
Simola et al., 2012, 2014), whereas other drugs do not produce differences in total 50 kHz vocalizations. such as morphine, 3,4-methylenedioxymethamphetamine, and nicotine (Wright et al., 2010; Sadananda
et al., 2012; Simola et al., 2010; 2014; Swalve et al., 2016). Vocalization
patterns are also known to change over time, as seen with amphetamine and nicotine (Simola et al., 2014; Swalve et al., 2016). Acoustic features of 50 kHz vocalizations such as maximum frequency and
bandwidth have recently been identified as a method for further examination of psychoactive substances and may have behavioral significance (Brudzynski, 2005; Simola et al., 2012), potentially encoding such information as magnitude or urgency of the signal, but few
studies have examined these features after drug administration (Simola et al., 2012). Stimulants such as methylphenidate and nicotine
differentially affect the acoustic features of 50 kHz vocalizations, with
methylphenidate increasing the maximum frequency and bandwidth,
whereas nicotine only increased bandwidth, suggesting that class and
type of stimulant differentially affects acoustic features, yet sensitivity
of these features to chronic use of drugs is currently unknown.
This study examined the long-term alterations in acoustic features
of 50 kHz vocalizations produced by two drugs of abuse, phencyclidine (PCP) and nicotine. In a previous study, we found that chronic but
not acute nicotine increased 50 kHz vocalizations, whereas PCP acutely
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decreased the total number of vocalizations (Swalve et al., 2016). However, the long-term effects of nicotine on features such as bandwidth
and maximum frequency as well as the potential significance of these
chronic alterations are unknown. We hypothesized that nicotine would
increase the maximum frequency and bandwidth similar to Simola et
al. (2012), with frequency increasing over time. However, as the acoustic features of vocalizations during PCP exposure have never been examined, the direction of its effect cannot be predicted.
Methods
Subjects
Twenty-four male Sprague-Dawley rats (age 7–9 weeks, 275–299 g
upon arrival) from Harlan Inc. (Indianapolis, Indiana, USA) were used.
All rats were single-housed in clear rectangular polycarbonate tubs
(48.3 cm × 26.7 cm × 20.3 cm) after arrival to avoid isolation-induced
stress and vocalizations that would occur during the experimental procedures if rats were pair-housed. This dataset was analyzed for a prior
experiment (Swalve et al., 2016) but all data reported here are new
and have never been reported before. Rats had at least 5 days of habituation to the animal facility with 5 min of handling per day before
experimental sessions commenced. Experiments were conducted during the light portion of a 12-h light/dark cycle (lights on from 6: a.m.
to 6: p.m.). Housing facilities were maintained at ∼22°C with relative
humidity of 45–60%. Food and water were both freely available ad libitum throughout all phases of the experiment. All experiments were
approved by the University of Nebraska–Lincoln Institutional Animal
Care and Use Committee.
Apparatus
Eight identical two-way shuttle boxes, custom designed and manufactured by Med Associates (St Albans, Vermont, USA), housed in ventilated, sound-insulated isolation cubicles (96.52 cm width × 35.56 cm
diameter × 63.5 cm height), were used as chambers. Each shuttle box
was (64 cm × 30 cm × 24 cm) divided into two equal-sized compartments by a white PVC partition with a doorway (15 cm × 9 cm) with
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an aluminum hurdle between the two compartments and a grid floor.
A houselight (50 V) was located at the top of each chamber. All experimental sessions were controlled by Med Associates programs. Background noise (∼74 dB) and ventilation was provided by a fan affixed
outside of the chamber in the sound-attenuating cubicle. An USV microphone (P48 Avisoft Bioacoustics/Emkay Microphone; Avisoft Bioacoustics, Berlin, Germany) was mounted on the ceiling of experimental chamber, connected by an E-MU 0404 USB Audio device to
a computer. Acoustic data were displayed in real time by the Avisoft
RECORDER, a multichannel triggering hard-disk recording software
(version 3.4; Avisoft Bioacoustics). Data were recorded at a sampling
rate of 192 kHz in 16-bit format (version 4.51; Avisoft Bioacoustics).
Procedure
Each rat was habituated to the chambers for 30 min per day on 2 concurrent days. Pre-injections of nicotine were given to each rat 2 h after each habituation day in their home cages to limit the initial aversive effect of nicotine (Bevins and Besheer, 2001). Vocalizations of
these animals had previously been used to examine the interaction
of nicotine and PCP on total and categorized vocalizations (Swalve et
al., 2016). In this experiment, four groups of rats were examined, divided into groups based on drug administration: SAL, SAL–NIC 0.2
mg/kg (NIC2), SAL–NIC 0.4 mg/kg (NIC4), and PCP. Over 7 total days,
rats were injected with their corresponding drugs and placed into the
chambers for 30 min, during which USVs were recorded.
Spectrograms were generated from the sound files using RavenPro
1.5 (Cornell Laboratory of Ornithology, Ithaca New York: 512 sample
Fourier transformation with a Hann window function; filter bandwidth
135 Hz; frequency resolution 93.8 Hz; grid time resolution 2.13 ms).
Each spectrogram was visually inspected by two separate trained scorers with an inter-rater reliability of 0.94. The scorers isolated each vocalization from the background noise and the acoustic features (minimum and maximum frequency, and duration) were calculated using
the automatic measurement feature in RavenPro. Bandwidth was calculated by taking the maximum frequency and subtracting the minimum frequency for each call.
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Drugs
(−) Nicotine tartrate salt (0.2 mg/kg or 0.4 mg/kg; Sigma Aldrich, St
Louis, Missouri, USA) was dissolved in 0.9% saline to a final pH of 7.0
± 0.2. Doses are expressed as base. Phencyclidine hydrochloride was
obtained from the NIDA Chemical Synthesis and Drug Supply Program
(Bethesda, Maryland, USA) and was mixed with 0.9% saline. All drugs
were administered subcutaneously before placement in the chamber,
with PCP administered 10 min and nicotine administered 5 min before
placement. Two injections were given with at least one injection consisting of saline due to parameters established for Swalve et al. (2016).
Statistical analyses
Owing to unequal call numbers elicited by each subject, subjects with
a minimum of 10 calls each day were selected and the means of each
acoustic feature were used in all subsequent analyses (see Table 1
for number of subjects and calls included; see Swalve et al., 2016 for
analysis of number of calls). Seven rats were excluded due to this criteria (one from NIC2, one from NIC4, three from PCP, and two from
saline only). Only 50 kHz calls (range: 35–95 kHz) were examined for
this analysis given the low numbers of 22 kHz calls. Data across 7 days
from the two nicotine (0.2 and 0.4 mg/kg) administrations were compared with the saline only administration using a mixed-model analysis of variance (ANOVA; drug × time) for each acoustic feature, followed by Fisher’s least significant difference pairwise comparisons.
Data across the 7 days from the PCP administration were compared
Table 1. Number of subjects in each condition and the average number of calls recorded per day of administration
Average number of 50 kHz vocalizations
Number of
Drug subjects
SAL
NIC2
NIC4
PCP

6
7
6
5

Day 1

Day 2

Day 3

Day 4

Day 5

Day 6

Day 7

602.83
303.71
218.50
223.80

272.00
278.14
247.67
178.40

190.17
211.57
191.33
242.80

189.00
208.86
226.17
253.00

189.33
221.00
187.17
234.20

173.00
242.86
216.33
223.40

116.33
192.57
172.17
227.20

NIC2, saline–nicotine (0.2 mg/kg); NIC4, saline–nicotine (0.4 mg/kg); PCP, phencyclidine; SAL,
saline.
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with the saline only condition using mixed-model ANOVAs (drug ×
time) for each acoustic feature, followed by Fisher’s least significant
difference pairwise comparisons. The criterion for statistical significance was P value less than 0.05.
Results
Nicotine
For nicotine administration, repeated-measures ANOVAs examining
the acoustic features (duration, bandwidth, and maximum frequency)
of the 50 kHz vocalizations found significant effects on the frequency
measures but no significant effects of drug, time, nor interactions on
the duration of calls (SAL: M = 0.049, SE = 0.001; NIC2: M = 0.046,
SE = 0.001; NIC4: M = 0.046, SE = 0.001; NS). There was no significant main effect of drug nor interaction between drug and time on
maximum frequency of 50 kHz calls. There were, however, significant
changes in the maximum frequency across the 7 days of administration regardless of drug-type/dose [F(6, 96) = 2.82, P < 0.02, η2 = 0.15]
with significantly lower maximum frequency for calls emitted on day
1 compared with subsequent days (P <0.01; Fig. 1). Follow-up repeated-measures ANOVAs, examining maximum frequency changes
in 50 kHz subcategories across time, found that downward ramp, inverted-U, step down, and trill calls had significantly lower maximum
frequency on day 1 (P < 0.05).

Figure 1. Rat 50 kHz vocalizations had a lower (a) maximum frequency (Hz) on day
1 of administration (**P<0.01, ***P<0.001) but there were no differences (b) in maximum frequency (Hz) between the drug treatments (P>0.05). NIC2, saline–nicotine
(0.2 mg/kg); NIC4, saline–nicotine (0.4 mg/kg); SAL, saline.
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Figure 2. Mean bandwidth (Hz) during nicotine administration (a) was smaller in
both NIC groups compared with saline (*P<0.05) but (b) did not change across the
7 days of treatment. NIC2, saline–nicotine (0.2 mg/kg); NIC4, saline–nicotine (0.4
mg/kg); SAL, saline.

A repeated-measures ANOVA found significant changes in the
bandwidth of the 50 kHz calls during nicotine administration. There
was a significant main effect of drug [F(2, 16) = 3.83, P < 0.05, η2 =
0.32; Fig. 2a]. Pairwise comparisons showed that bandwidth was significantly smaller for rats administered NIC2 (Hz; M = 12285.62, SE
= 1018.90, P <0.025) and NIC4 (Hz; M = 12625.85, SE = 1100.54, P
< 0.05) compared with those administered saline (M = 16110.57, SE
= 1100.54) but there was no significant difference between the two
nicotine doses. There was no significant effect of time nor interaction
between drug and time on the bandwidth of 50 kHz calls, although
the interaction was trending towards significance (P = 0.052; Fig. 2b).
Follow-up one-way ANOVAs, examining the subcategories of 50-kHz
USVs, determined that complex calls decreased in bandwidth following low dose nicotine administration (P <0.05), and downward ramp
and multistep calls had decreased bandwidth after high dose nicotine
administration compared with saline (P < 0.05; Table 2).
Phencyclidine
For PCP administration, repeated-measures ANOVAs examining the
acoustic features of the 50 kHz vocalizations (duration, bandwidth,
and maximum frequency) showed that PCP and length of administration led to changes in frequency measures (Hz) but there were no
significant changes in call duration between PCP (M = 0.050, SE =
0.002) and SAL (M = 0.049, SE = 0.002) administration or across administration days.
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Table 2. Average bandwidth (kHz) and SDs for each 50-kHz ultrasonic vocalization
subcategory
Bandwidth [mean (SD)]
Category
Complex
Composite
Downward ramp
Flat
Flat trill
Inverted-U
Multistep
Short
Split
Step down
Step up
Trill
Trill with jumps
Upward ramp

SAL
10.93 (1.75)
32.68 (3.92)
10.50 (2.99)
2.88 (0.81)
–
10.08 (3.90)
27.27 (2.56)
4.85 (–)
42.15 (1.89)
22.58 (4.45)
21.87 (3.65)
14.00 (3.95)
28.91 (3.72)
9.52 (2.41)

NIC2
8.87 (0.69)*
28.86 (–)
7.72 (0.70)
2.60 (0.13)
–
9.64 (0.76)
23.02 (0.94)
3.95 (0.15)
39.69 (–)
19.77 (0.02)
21.34 (2.27)
10.38 (0.75)
25.70 (1.38)
8.75 (1.05)

NIC4
9.09 (2.11)
–
6.93 (1.30)*
2.75 (–)
–
8.29 (0.57)
20.56 (4.20)*
–
–
–
20.46 (2.01)
11.29 (4.76)
26.55 (0.61)
9.04 (3.18)

PCP
9.60 (2.04)
28.78 (2.23)
5.81 (0.77)*
2.37 (0.88)
–
9.42 (0.51)
29.25 (6.79)
3.53 (–)
37.46 (–)
15.45 (–)
23.20 (2.92)
12.81 (3.63)
29.17 (3.37)
8.37 (1.84)

NIC2, saline–nicotine (0.2 mg/kg); NIC4, saline–nicotine (0.4 mg/kg); PCP, phencyclidine;
SAL, saline.
*P <0.05, significant difference compared with saline administration.

There was no significant main effect of drug nor interaction between drug and time on maximum frequency of 50 kHz calls emitted
by rats. However, there were significant changes in the maximum frequency across the 7 days of administration regardless of drug-type
[F(6, 54) = 2.67, P<0.05]. Pairwise comparisons revealed that calls
emitted on day 1 of administration had significantly lower maximum
frequency than all subsequent days (P<0.05; Fig. 3). Follow-up repeated-measures ANOVAs, examining maximum frequency changes
in 50 kHz subcategories across time, found that flat and step-up
calls had significantly lower maximum frequency on day 1 (P<0.05).
Bandwidth, in contrast, was affected by drug administration. Rats
receiving PCP treatment had significantly smaller bandwidth (Hz; M
= 12411.18, SE = 1054.37) compared with those administered saline
(M = 16110.57, SE = 962.50) [F(1, 9) = 6.72, P<0.05; Fig. 4a]. There
was no significant effect of time on bandwidth, and no significant
drug x time interaction; though pairwise comparisons between drugtype on each day of administration, showed that PCP only had significantly smaller bandwidth on days 1, 4, and 5 (P<0.05; Fig. 4b). Follow-up one-way ANOVAs, examining the subcategories of 50-kHz

Swalve et al. in Behavioural Pharmacology 30 (2019)

9

Figure 3. Rat 50 kHz vocalizations had a lower (a) maximum frequency (Hz) on day
1 of administration (*P<0.05, **P<0.01), but there was no difference (b) between
the PCP and saline treatment groups. PCP, phencyclidine; SAL, saline.

Figure 4. PCP administration (a) decreased the bandwidth of 50 kHz vocalizations
compared with saline administration (*P< 0.05) and (b) resulted in change across
the 7 days of administration. PCP, phencyclidine; SAL, saline.

USVs, determined that only downward ramp calls had significantly
decreased bandwidth after PCP administration compared with saline (P<0.05; Table 2).
Discussion
This study examined the alteration in acoustic features of 50-kHz USVs
induced by nicotine and PCP exposure. Nicotine did not affect the duration or maximum frequency of calls but decreased bandwidth. PCP
administration led to changes in frequency measures, including a decrease in bandwidth compared with saline. In addition, there was a
general trend of increasing maximum frequency levels over days for
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all calls, not dependent on the drug group. This study is the first to
show that PCP alters the acoustic features of USVs over time.
Both a low and a high dose of nicotine (0.2 and 0.4 mg/kg) led to
a decrease in bandwidth but did not alter other features such as call
duration or maximum frequency. In addition, bandwidth decreases
in complex, downward ramp, and multistep calls contributed to this
overall decrease after nicotine administration. This finding is somewhat in opposition to the study of Simola et al. (2012). Although the
finding that a low dose of nicotine (e.g. 0.2 mg/kg) was not enough
to evoke differences in frequency measures is similar to that of Simola
et al. (2012), they found an increase in both maximum frequency and
bandwidth with the high dose (e.g. 0.4 mg/ kg) and no differences in
bandwidth of the 50-kHz USV subcategories.
The lack of modification of maximum frequency and contradictory
alterations in bandwidth between the current findings and Simola et
al. (2012) could be explained by methodological differences. In Simola
et al. (2012), recording sessions lasted 2 h, compared with the 30min
sessions used here. One potential explanation for this difference is
that a decrease in the total number of vocalizations due to the shortened testing length might have led to low levels of vocalizations, during which differences in certain features such as maximum frequency
could have been masked due to a lack of data points. However, even
within a shortened session, a minimum of 10 calls were examined,
with an average of 211 calls, higher than those previously reported in
Simola et al. (2012), suggesting that such an effect was not likely and
was not seen in our study. Indeed, other differences in the methodology between this work and Simola et al. (2012), such as chamber
composition, latency to start recording, and total days of acclimation,
could potentially explain differences between their findings and ours.
Given the contrast in findings, future research on the short-term and
long-term effects of nicotine on acoustic features of vocalizations is
strongly recommended, including an exploration of parametric work
on the environment most likely to produce vocalization differences.
Similar to that seen with nicotine, PCP exposure led to smaller
bandwidth compared with saline groups. Upon further examination
of subcategories, PCP administration reduced bandwidth in downward ramp calls. The specific modification of bandwidth in comparison to other acoustic features suggests that this feature might relate to certain aspects of communication. This literature suggests that
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vocalizations can be subdivided into 22 and 50 kHz in relation to affective states (Knutson et al., 1999; Burgdorf et al., 2000; Brudzynski, 2005; Litvin et al., 2007). However, it is possible that alterations of
bandwidth may also be implicated in affective state. Indeed, bandwidth and other acoustic features have been purported to play a significant role in communication (Brudzynski, 2005) and may ‘convey
physiological states’ (Stewart et al., 2015), as decreased bandwidth was
associated with increased heart rate, which may be related to distress.
The role of bandwidth in communication is comparatively unknown
and its relation to the reinforcing value of drugs is unknown. Nicotine is purportedly reinforcing and increased bandwidth in Simola et
al. (2012), along with other drugs that induce rewarding states such
as morphine and methylphenidate, but decreased bandwidth in this
study. PCP, in direct contrast, produces a decrease in rewarding states
(Spielewoy and Markou, 2003) and decreased bandwidth in this study.
In addition, both D1 and D2 antagonists significantly decrease bandwidth (Ringel et al., 2013), and dopamine is linked to many aspects of
continued drug use including motivation and reward-related stimuli
(Berridge and Robinson, 1998). Thus, alterations in bandwidth may be
related to properties of drugs other than reinforcement, which should
be examined in future studies.
Neither PCP nor nicotine altered maximum frequency, although rats
in all groups showed an increase in maximum frequency over days.
This increase in maximum frequency was primarily driven by low maximum frequency on the first day of testing in all groups. It may be possible that experimental parameters could be the cause of low maximum frequency on the first day, such as the potential stressor of the
injections; however, animals in the nicotine group had previously undergone injections in their home cage so any alterations in vocalizations due to injections should have been diminished in at least one
of the four groups. Although this acoustic feature may not be integral in examining the effects of drugs, determining how vocalizations
change over time is important in future research on vocalizations.
Maximum frequency was altered by nicotine administration in Simola
et al. (2012) and this particular feature has been suggested to be of
particular importance in communication (Brudzynski, 2005). Links between maximum or peak frequency and hedonic aspects of drugs
have also been hypothesized, as dopamine antagonists differentially
disrupted this measure (Ringel et al., 2013). Further examination of
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drug-induced alterations of acoustic features over time is warranted,
as well as elucidation of natural changes in bandwidth and frequency
and whether these are affected by specific environmental conditions.
Chronic treatment with both PCP and nicotine significantly decreased bandwidth. Maximum frequency was not altered dependent
on drug exposure but increased over time. These findings suggest that
acoustic features of natural and drug-induced USVs may change over
time and future research on USVs as a measure of affective states in
rats should take this variable into account.
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